News & Articles

The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions

Huber's high precision temperature control technology directed towards manufacturing test chemicals and PPE

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2

Join this upcoming webinar for a review of an antibody discovery campaign targeting a cell surface receptor implicated in cancer

Emergency use authorization granted for new biomaterial collection approach

The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers

SelectScience hears from Prof. Harald Kolmar, TU Darmstadt, on an exciting new approach in cancer therapy

To be in with a chance of winning a $500 Amazon voucher, simply cast your vote for the product that has made the most difference to your research

Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis

Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals

The test results are designed to enable differential diagnosis in under 2.5 hours

Recent funding from the BARDA award helped the company accelerate development and validation

In the wake of the pandemic, the strategic partnership aims to increase antigen production for diagnostic kits and vaccine development

New IgM and IgG antibody assays will help indicate whether a person has developed immunity against COVID-19

The scientific community is working at full speed to fight the severe acute respiratory syndrome

The rapid delivery program is designed to provide critical laboratory equipment in this time of need

Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines

The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients

Discover how using Protein A and His1K biosensors can reduce the time of screening for bispecific antibodies

OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic

These are some of the first antibody detection tests to be CE marked in Europe and available for COVID-19 testing